Drupal.behaviors.print = function(context) {window.print();window.close();}>
Bruker Q3 Revenues Up 35 Percent; CEO Predicts Funding Shift Toward Proteomics
October 28, 2011
Bruker Q3 Revenues Up 35 Percent; CEO Predicts Funding Shift Toward Proteomics
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
At JP Morgan Mass Spec Vendors Highlight Clinical Efforts, Performance of High-Profile Releases
January 11, 2013 / ProteoMonitor
Mass Spec Informatics and Applications Take Center Stage at ASMS 2012
May 25, 2012 / ProteoMonitor
Pittcon 2012 Light on LC-MS Product Releases, But Offers Insights into Vendors' Clinical Plans
March 16, 2012 / ProteoMonitor
At JP Morgan, Vendors Tout Strong Mass Spec Releases as Antidotes to Academic/Government Gloom
January 13, 2012 / ProteoMonitor
Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor